The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 62,576 | 13,633,220 | SH | SOLE | 13,633,220 | 0 | 0 | ||
ACORDA THERAPEUTICS INC | COM | 00484M106 | 17,735 | 900,259 | SH | SOLE | 900,259 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 12,018 | 836,337 | SH | SOLE | 836,337 | 0 | 0 | ||
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 19,643 | 1,396,071 | SH | SOLE | 1,396,071 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 154,920 | 5,580,690 | SH | SOLE | 5,580,690 | 0 | 0 | ||
AVEO PHARMACEUTICALS INC | COM | 053588109 | 18,727 | 8,435,584 | SH | SOLE | 8,435,584 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 107,633 | 1,310,046 | SH | SOLE | 1,310,046 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 28,702 | 5,162,242 | SH | SOLE | 5,162,242 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO LTD | COM | G11196105 | 61,209 | 2,448,350 | SH | SOLE | 2,448,350 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 7,699 | 2,428,571 | SH | SOLE | 2,428,571 | 0 | 0 | ||
ESPERION THERAPEUTICS INC | COM | 29664W105 | 33,855 | 731,531 | SH | SOLE | 731,531 | 0 | 0 | ||
G1 THERAPEUTICS INC | COM | 3621LQ109 | 46,813 | 2,684,244 | SH | SOLE | 2,684,244 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,350 | 591,070 | SH | SOLE | 591,070 | 0 | 0 | ||
MYOVANT SCIENCES LTD | COM | G637AM102 | 32,848 | 2,807,550 | SH | SOLE | 2,807,550 | 0 | 0 | ||
PROTEON THERAPEUTICS INC | COM | 74371L109 | 2,040 | 1,337,462 | SH | SOLE | 1,337,462 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 25,333 | 1,351,808 | SH | SOLE | 1,351,808 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 22,486 | 497,157 | SH | SOLE | 497,157 | 0 | 0 | ||
IGNYTA INC | COM | 451731103 | 41,576 | 4,016,990 | SH | SOLE | 4,016,990 | 0 | 0 | ||
SANGAMO THERAPEUTICS INC | COM | 800677106 | 11,000 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 7,035 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 131,849 | 7,088,651 | SH | SOLE | 7,088,651 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 21,383 | 1,474,688 | SH | SOLE | 1,474,688 | 0 | 0 |